section name header

Information

AHFS Class:

44:00 Enzymes


Generic Name

Products

Hyaluronidase is supplied as a 150-unit/mL solution in 1-mL fill vials. Each mL also contains sodium chloride 8.5 mg, edetate disodium 1 mg, calcium chloride 0.4 mg, and thimerosal not more than 0.1 mg in sodium phosphate buffer.1(11/05)

pH

From 6.4 to 7.4.4

Osmolality

From 295 to 355 mOsm/kg.1(11/05)

Trade Name(s)

Amphadase

Administration

Hyaluronidase is administered subcutaneously, intradermally, or intramuscularly along with other drugs or solutions. The solutions should be isotonic for subcutaneous administration. It should not be administered intravenously.1(11/05); 4

Stability

Hyaluronidase injection in intact vials should be stored under refrigeration at 2 to 8°C. It should not be used if it is discolored or contains a precipitate.4

Hyaluronidase (Wyeth) 75 units/mL in citric acid/sodium citrate buffer (pH 4.5) was found to lose about 7 to 8% activity in 24 hours at 4 and 23°C. Hyaluronidase activity decreased by 25 to 33% in 48 hours.1907

Compatibility

Solution Compatibility

Additive Compatibility

Drugs in Syringe Compatibility

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions March 22, 2023. © Copyright, 2024. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.